On November 5, 2026, fourteen insiders at Lyell Immunopharma, Inc. (LYEL) collectively purchased approximately $350 million worth of the company's stock. These significant purchases were made at a price of $10.77 per share.
Among the notable buyers were ten percent owners Paul L. Berns, Keith Crandell, Robert Nelsen, Clinton Bybee, Steven Gillis, and Kristina Burow, each acquiring 2,321,262 shares. Several entities affiliated with Arch, including Venture Fund Xiii, L.P., Venture Partners Xiii, Llc, Venture Partners Xiii, L.P., Venture Fund Ix, L.P., Venture Fund Ix Overage, L.P., Venture Partners Ix Overage, L.P., Venture Partners Ix, L.P., and Venture Partners Ix, Llc, also made identical purchases.
This cluster buying activity, where multiple insiders purchase shares concurrently, is often viewed as a strong bullish indicator by market observers.